Literature DB >> 15489209

Dietary iron promotes azoxymethane-induced colon tumors in mice.

Jillian N M Ilsley1, Glenn S Belinsky, Kishore Guda, Qi Zhang, Xi Huang, Jeffrey B Blumberg, Paul E Milbury, L Jackson Roberts, Richard G Stevens, Daniel W Rosenberg.   

Abstract

There is accumulating evidence that high levels of dietary iron may play a role in colon carcinogenesis. We used a mouse model to investigate the impact of elevated dietary iron on incidence of aberrant crypt foci (ACF; a preneoplastic lesion) on tumor formation and on induction of oxidative stress. A/J mice were injected intraperitoneally, once a week for 6 weeks, with the colonotropic carcinogen, azoxymethane (AOM) or saline (vehicle controls). Following AOM or saline treatments, mice were placed on diets of high (3,000 ppm) and low (30 ppm) iron. Mice in each treatment group were sacrificed at 6 and 10 weeks following the final injection with AOM or saline. Colons were removed for subsequent histopathological analysis, which revealed average increases of 4.6 +- 1.3 vs. 10.4 +- 2.5 total tumors at 6 weeks and 30.75 +- 2.7 vs. 41.5 +- 4.4 total tumors at 10 weeks per AOM-treated mouse on low- and high-iron diets, respectively. There were no significant differences in incidence of ACF attributable to iron, although there was a trend toward greater crypt multiplicity per focus in mice on high-iron diets. Notably, no tumors were observed in mice receiving vehicle control injections in place of carcinogen, regardless of the level of dietary iron. These data suggest that iron exerts its effect at the stage of tumor promotion, but is not sufficient to initiate tumor formation. To learn more about mechanisms by which iron promotes tumor growth, colons were assayed for several biomarkers of oxidative stress [BOS; total F2-isoprostanes (F2-IsoPs), 15-F2t-isoprostanes (8-IsoPGF2s), Isofurans (IsoFs), and 8-hydroxyguanosines (8-OH[d]Gs)], as well as iron absorption, programmed cell death, and cellular proliferation. Elevated PCNA and TUNEL staining of the colon epithelium revealed hyperproliferative and apoptotic responses to iron, while no significant differences between iron groups were observed in each of the BOS that were assayed. Our results suggest that, following carcinogen exposure, elevated dietary iron promotes the growth of tumors with altered cellular homeostasis through a mechanism that is independent of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489209     DOI: 10.1207/s15327914nc4902_7

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  13 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine.

Authors:  Audrey Ferrand; Shamilah Lachal; Gianni Bramante; Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-15       Impact factor: 4.052

3.  Iron: an emerging factor in colorectal carcinogenesis.

Authors:  Anita C G Chua; Borut Klopcic; Ian C Lawrance; John K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

4.  Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis.

Authors:  Jonathan Eckard; Jisen Dai; Jing Wu; Jinlong Jian; Qing Yang; Haobin Chen; Max Costa; Krystyna Frenkel; Xi Huang
Journal:  Cancer Cell Int       Date:  2010-08-19       Impact factor: 5.722

Review 5.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 6.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

7.  Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.

Authors:  S J Ford; P Obeidy; D B Lovejoy; M Bedford; L Nichols; C Chadwick; O Tucker; G Y L Lui; D S Kalinowski; P J Jansson; T H Iqbal; D Alderson; D R Richardson; C Tselepis
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 8.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

9.  Effects of selenium on colon carcinogenesis induced by azoxymethane and dextran sodium sulfate in mouse model with high-iron diet.

Authors:  Jun-Hyeong Kim; Jin-Joo Hue; Bong Su Kang; Hyunji Park; Sang Yoon Nam; Young Won Yun; Jong-Soo Kim; Beom Jun Lee
Journal:  Lab Anim Res       Date:  2011-03-25

10.  Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis.

Authors:  Lavanya Reddivari; Venkata Charepalli; Sridhar Radhakrishnan; Ramakrishna Vadde; Ryan J Elias; Joshua D Lambert; Jairam K P Vanamala
Journal:  BMC Complement Altern Med       Date:  2016-08-09       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.